Drug Discovery in the Developing World; a Medicinal Chemistry perspective
The University of Liverpool Medicinal Chemistry Group (UK) is involved in multiple projects which aim to provide new and improved therapies to treat several diseases within the developing world. To highlight our work in this area this article focuses on two current projects targeting tuberculosis and cryptococcal meningoencephalitis.
Please sign in or register for FREE to view this content
Sign in to MedChemNet
Register to MedChemNet – the medicinal chemistry network
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.